The ECSIT protein is encoded by the ECSIT gene located on chromosome 19 in humans. The recombinant form of ECSIT is typically expressed in Escherichia coli (E. coli) and is often tagged with a polyhistidine (His) tag to facilitate purification. The recombinant human ECSIT protein consists of 201 amino acids and has a predicted molecular mass of approximately 22.9 kDa .
ECSIT is an adapter protein involved in the Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling pathways. These pathways are essential for the activation of NF-kappa-B (NF-κB), a transcription factor that regulates the expression of genes involved in immune and inflammatory responses . ECSIT specifically interacts with TRAF6 (TNF receptor-associated factor 6) and MEKK-1 (MAP3K1), facilitating the activation of NF-κB .
In addition to its role in immune signaling, ECSIT is also involved in mitochondrial function. It is required for the efficient assembly of mitochondrial NADH:ubiquinone oxidoreductase (complex I), which is a critical component of the mitochondrial respiratory chain . Knockdown of ECSIT results in impaired complex I assembly and disturbed mitochondrial function .
Recombinant human ECSIT protein is widely used in research to study its role in various cellular processes. It is particularly valuable in investigating the mechanisms of immune response and mitochondrial function. The protein is also used in the development of therapeutic strategies targeting immune and inflammatory diseases.